Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 17, 2007 - Issue 1
Submit an article Journal homepage
24
Views
2
CrossRef citations to date
0
Altmetric
Patent Evaluation

Fused thiazole derivatives having affinity for the histamine H3 receptor

Glaxo Group Limited: WO2006097691

Harry R Howard CNS – Discovery Chemistry, PGRD Groton Laboratories, Pfizer Inc., Groton, CT 06340, USA. Email:[email protected]
Pages 129-131 | Published online: 03 Jan 2007

Bibliography

  • ARRANG JM, GARBURG M, SCHWARTZ JC: Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature (1983) 302:832-837.
  • LEURS R, BLANDINA P, TEDFORD C, TIMMERMAN H: Therapeutic potential of histamine H3 receptor agonists and antagonists. Trends Pharm. Sci. (1998) 19(5):177-183.
  • GIOVANNINI MG, BARTOLINI L, BACCIOTTINI L, GRECO L, BLANDINA P: Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine- induced amnesia. Behav. Brain Res. (1999) 104:147-155.
  • SMIT MJ, TIMMERMAN H, HIJZELENDOORN JC, LEURS R: Regulation of the human histamine H1 receptor stably expressed in Chinese hamster ovary cells. Br. J. Pharmacol. (1996) 117(6):1071-1080.
  • FUKUI H, FUJIMOTO K, MIZUGUCHI et al.: Molecular cloning of the human histamine H1 receptor gene. Biochem. Biophys. Res. Commun. (1994) 201(2):894-901.
  • SULLIVAN E, TUCKER E, DALE I: Measurement of [Ca2+] using the fluorometric imaging plate reader (FLIPR). In: Methods in Molecular Biology: Calcium Signaling Protocols. Lambert DG (Ed.). Humana Press, New Jersey, (1999):125-136.
  • AXE FU, BEMBENEK SD, SZALMA S: Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore. J. Mol. Graphics Mod. (2006) 24(6):456-464.
  • DEESCH IJ, MILLS JEJ, PERKINS TD et al.: Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE. J. Med. Chem. (2001) 44(11):1666-1674.
  • WILSON D: The discovery of a novel series of potent, orally active histamine H3 receptor antagonists. Proceedings of the 13th RSC-SCI Medicinal Chemistry Symposium. Cambridge, UK (2005).
  • CURRENT PATENTS GAZETTE: Thomson Scientific (2005) Issue 0538:13.
  • HOWARD HR: 7-Phenylsulfonyl- tetrahydro-3-benzazepine derivatives as antipsychotic agents. Exp. Opin. Ther. Patents (2005) 15(12):1811-1815.

Patents

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.